Vox summarizes the United States Department of Agriculture and the U.S. Food and Drug Administration’s March formal agreement, which outlines the joint regulatory framework for cultivated meat.
Following up on their joint statement from last year, the FDA and USDA have released a Formal Announcement spelling out their joint oversight of cell-based meat and poultry production in the United States.
GFI’s Director of Policy Jessica Almy teams up with R Street Fellow Shoshana Weissmann to lay out the case against protectionist and unconstitutional governmental censorship of product labels.
Arizona Daily Star publishes GFI’s Senior Communications Specialist Matt Ball’s op-ed on Arizona’s failed label censorship bill, explaining that it violated free speech and free markets.
New York Times gives an overview of label censorship laws, highlighting that the industry groups urging legislators to introduce such laws are threatened by alternative proteins.
GFI’s comment discusses the role labels serve on plant-based dairy products. Learn why FDA should not restrict plant-based dairy’s clear labels.
Together with Avant Meats, BlueNalu, Finless Foods, Mosa Meat, New Age Meats, Seafuture, and SuperMeat, we lay out the need for clear and fair regulatory structures clean (aka cell-based) meat.
GFI’s comment applauds USDA and FDA’s commitment to working together to ensure the safety of cultivated meat. Learn why we support the joint regulatory framework.
GFI Policy Director Jessica Almy discusses pivotal developments in plant-based and cell-based meat regulation, illuminates key work by the GFI policy team along the way, and lays out what still needs to be done.
Mark the date: November 16, 2018 was the day that clean/cell-based meat's path to market became much clearer in the United States. On that day, the FDA and USDA announced details of how they will oversee clean/cell-based meat from cows, pigs, chickens, and turkeys.
